Patient motivation for participating in clinical trials for depression: validation of the motivation for clinical trials inventory-depression

被引:9
|
作者
Andresen, Emily L. [1 ,2 ]
Wilson, Kimberly A. [1 ]
Castillo, Adelaida [1 ]
Koopman, Cheryl [1 ]
机构
[1] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA
[2] Palo Alto Univ, Pacific Grad Sch Psychol, Palo Alto, CA USA
关键词
depression; measure; motivation; randomized clinical trial; recruitment; RANDOMIZED CONTROLLED-TRIAL; PSYCHIATRIC-DISORDERS; ECONOMIC BURDEN; PATIENTS POINT; ATTITUDES; ANTIDEPRESSANTS; SCHIZOPHRENIA; PSYCHOTHERAPY; WILLINGNESS; PREFERENCES;
D O I
10.1097/YIC.0b013e328332055c
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The motivation for clinical trials inventory-depression (MCTI-D) was developed and evaluated for assessing motivations to participate in clinical trials on depression. Sixty-four participants completed the MCTI-D: 40 individuals expressing interest in participating in a randomized clinical trial (RCT); and 24 clinic patients receiving traditional care for depression. Content validity was supported by feedback derived from a panel of experts in depression research and respondents completing the measure. The motivation most frequently endorsed for participating in an RCT was the desire to help others and/or to further science. The potential stigma associated with seeing a psychiatrist was reported to have the least influence. Patients expressed a greater likelihood to participate in RCTs that involved psychotherapy than in experimental medication or placebo-controlled trials. Data from the MCTI-D may provide useful information for depression researchers to consider as possible influences on patients' decisions about whether or not they will participate. Int Clin Psychopharmacol 25:7-16 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 50 条
  • [1] Motivation and barriers to participation in clinical trials
    Gaul, Charly
    Schmidt, Thomas
    Helm, Juergen
    Hoyer, Heike
    Haerting, Johannes
    MEDIZINISCHE KLINIK, 2006, 101 (11) : 873 - 879
  • [2] Patient Health Questionnaire Anxiety and Depression Scale: Initial Validation in Three Clinical Trials
    Kroenke, Kurt
    Wu, Jingwei
    Yu, Zhangsheng
    Bair, Matthew J.
    Kean, Jacob
    Stump, Timothy
    Monahan, Patrick O.
    PSYCHOSOMATIC MEDICINE, 2016, 78 (06): : 716 - 727
  • [3] Criteria for efficacy of clinical trials in depression
    Hackett, D
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S84 - S85
  • [4] Application of Biomarkers in Depression Clinical Trials
    Marangell, Lauren
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 31S - 31S
  • [5] CLINICAL TRIALS OF ETNS FOR DEPRESSION AND PTSD
    Cook, I. A.
    EPILEPSIA, 2012, 53 : 246 - 247
  • [6] Depression and cardiovascular disease: Time for clinical trials
    Catalina-Romero, Carlos
    Calvo-Bonacho, Eva
    ATHEROSCLEROSIS, 2017, 257 : 250 - 252
  • [7] MEASUREMENT OF DEPRESSION IN CLINICAL-TRIALS - AN OVERVIEW
    HUGHES, JR
    OHARA, MW
    REHM, LP
    JOURNAL OF CLINICAL PSYCHIATRY, 1982, 43 (03) : 85 - 88
  • [8] Bipolar depression: a review of randomised clinical trials
    Goodnick, Paul J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (01) : 13 - 21
  • [9] Phospholipid metabolism and depression: new clinical trials
    Horrobin, DF
    EUROPEAN PSYCHIATRY, 2002, 17 : 76S - 76S
  • [10] Placebo in clinical trials for depression - Complexity and necessity
    Kupfer, DJ
    Frank, E
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (14): : 1853 - 1854